NEW YORK (GenomeWeb) – The GenomeWeb Index of 31 firms operating in the molecular diagnostics and omics tools industries beat the broader stock market in June with four of the firms providing a double-digit increase in their stock prices.

Overall, the GenomeWeb Index climbed 2 percent month over month, compared to 2 percent declines for both the Dow Jones Industrial Average and the Nasdaq, and beating the Nasdaq Biotech Index, which closed up slightly more than 1 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.